Impact MF

Forum rules
- Comments must be civil and on topic
- Back up claims with evidence/reasoning/sources (posting links is allowed)
- No commercials/harassment/spam
Post Reply
Littlebiobet
Posts: 4
Joined: Fri Aug 24, 2018 4:16 am

Impact MF

Post by Littlebiobet » Sat Feb 08, 2025 11:36 pm

First patient dosed April 2023

50% enrollment achieved December 2023. We are now 14 months past this announcement, low end for BAT survival.

If 35% enrollment was achieved early 2023 mid 2025 would put us at 30 months.

240 patients enrolled December of 2024 80 being on BAT.

With this information. I’m assuming if we don’t hear from the company by July. We have met or exceeded median overall survival from the phase two study and will be granted appproval.
Top
Post Reply

Return to “ImetelChat”